Assessing National Public Health Law to Prevent Infectious Disease Outbreaks: Immunization Law as a Basis for Global Health Security

Abstract

Immunization plays a crucial role in global health security, preventing public health emergencies of international concern and protecting individuals from infectious disease outbreaks, yet these critical public health benefits are dependent on immunization law. Where public health law has become central to preventing, detecting, and responding to infectious disease, public health law reform is seen as necessary to implement the Global Health Security Agenda (GHSA). This article examines national immunization laws as a basis to implement the GHSA and promote the public's health, analyzing the scope and content of these laws to prevent infectious disease across Sub-Saharan Africa. Undertaking policy surveillance of national immunization laws in 20 Sub-Saharan African countries, this study: (1) developed a legal framework to map the legal attributes relevant to immunization; (2) created an assessment tool to determine the presence of these attributes under national immunization law; and (3) applied this assessment tool to code national legal landscapes. An analysis of these coded laws highlights legal attributes that govern vaccine requirements, supply chains, vaccine administration standards, and medicines quality and manufacturer liability. Based upon this international policy surveillance, it will be crucial to undertake legal epidemiology research across countries, examining the influence of immunization law on vaccination rates and disease outbreaks.

Get full access to this article

View all access options for this article.

References

Porta

, A Dictionary of Epidemiology, 6th ed. (Madison Avenue, New York, NY: Oxford University Press, 2008): at 143.

Id.

C. J. E.

Metcalf ,

Ferrari ,

A. L.

Graham , and

B. T.

Grenfell , “Understanding Herd Immunity,” Trends in Immunology 36, no. 12 (2015): 753–755, available at <https://doi.org/10.1016/j.it.2015.10.004> (last visited July 29, 2019).

See Id.

Plotkin

, “History of Vaccination,”

Proceedings of the National Academy of Sciences of the United States of America

111, no. 34 (2014): 12283–12287, available at <https://doi.org/10.1073/pnas.1400472111> (last visited July 29, 2019).

A. M.

Stern and

Markel , “The History Of Vaccines And Immunization: Familiar Patterns, New Challenges,” Health Affairs 24, no. 3 (2005): 611–621, available at <https://doi.org/10.1377/hlthaff.24.3.611> (last visited July 29, 2019).

WHO, “SmallPox,” available at <http://www.who.int/about/bugs_drugs_smoke_chapter_1_smallpox.pdf> (last visited July 29, 2019).

WHO, “Poliomyelitis,” 2018, available at <http://www.who.int/en/news-room/fact-sheets/detail/poliomyelitis> (last visited July 29, 2019)

S. P.

Trumbo ,

Silver ,

Domentic ,

Gasoyan ,

Paatashvili ,

B. G.

Gellin , and

J. L.

Gordon , “Strengthening Legal Frameworks for Vaccination: The Experiences of Armenia, Georgia, and Moldova,” Vaccine (In press).

10.

B. M.

Meier ,

Tureski ,

Bockh ,

Carr ,

Ayala ,

Roberts ,

Cloud ,

Wilhelm , and

Burris , “Examining National Public Health Law to Realize the Global Health Security Agenda,” Medical Law Review 25, no. 2 (May 1, 2017): 240–269.

11.

WHO, “Explorations of Inequality. Childhood Immunization,” Geneva, 2018.

12.

Greenwood

, “The Contribution of Vaccination to Global Health: Past, Present and Future,” Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 369, no. 1645 (2014): 20130433, available at <https://doi.org/10.1098/rstb.2013.0433> (last visited July 2019).

13.

Center for Disease Control, “Global Health Security Agenda,” 2018, available at <https://www.ghsagenda.org/about> (last visited July 29, 2019).

14.

Id.

15.

GHSA Commitment Development Meeting, Helsinki, Finland, May 5-6, 2014, Meeting Report, available at <https://ghsaindonesia.files.wordpress.com/2016/02/helsinki-meeting-report-finland-5-6-may-2014.pdf> (last visited January 12, 2019).

16.

Center for Disease Control, “Action Packages | Prevent 4-Immunization,” 2018, available at <https://www.ghsagenda.org/packages/p4-immunization> (last visited May 10, 2018).

17.

H.-W.

Cho and

Chu , “Out of Africa, into Global Health Security Agenda,” Osong Public Health and Research Perspectives 5, no. 6 (December 2014): 313–314, available at <https://doi.org/10.1016/j.phrp.2014.11.004> (last visited July 29, 2019).

18.

Busby ,

Grepin , and

Youde , “Introduction: Ebola: Implications for Global Health Governance,” Global Health Governance: The Scholarly Journal for the New Health Security Paradigm 10, no. 1 (2016): 3–10.

19.

WHO, “Report of the Ebola Interim Assessment Panel,” 2015;

Moon ,

Sridhar ,

M. A.

Pate ,

A. K.

Jha ,

Clinton ,

Delaunay ,

Edwin , et al., “Will Ebola Change the Game? Ten Essential Reforms before the next Pandemic. The Report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola,” The Lancet 386, no. 10009 (2015): 2204–2221, available at <https://doi.org/10.1016/S0140-6736(15)00946-0> (last visited July 29, 2019).

20.

Clinton and

Devi , Governing Global Health: Who Runs the World and Why? 1st ed. (Oxford University Press, 2017).

21.

Abayomi ,

Katz ,

Spence ,

Conton , and

S. M.

Gevao , “Managing Dangerous Pathogens: Challenges in the Wake of the Recent West African Ebola Outbreak,” Global Security: Health, Science and Policy 1, no. 1 (January 25, 2016): 51–57, available at <https://doi.org/10.1080/23779497.2016.1228431> (last visited July 29, 2019); GHSA Commitment Development Meeting, supra note 15.

22.

Center for Disease Control, “Where GHSA Is Active | Global Health Security Agenda,” 2018, available at <https://www.ghsagenda.org/where-ghsa> (last visited July 29, 2019).

23.

B. M.

Meier ,

Tureski ,

Bockh ,

Carr ,

Ayala ,

Roberts ,

Cloud ,

Wilhelm , and

Burris , “Examining National Public Health Law to Realize the Global Health Security Agenda,” Medical Law Review 25, no. 2 (May 1, 2017): 240–269, available at <https://doi.org/10.1093/medlaw/fwx020> (last visited July 29, 2019).

24.

L. O.

Gostin

, Global Health Law (Cambridge: Harvard University Press, 2014).

25.

L. O.

Gostin and

B. M.

Meier , “Global Health Law,” Journal of Law, Medicine & Ethics 47, no. 4 (2019) (forthcoming);

L. O.

Gostin

, “Good Science + Good Ethics = Good Law: Five Rules for Epidemic Preparedness,” The Milbank Quarterly 93, no. 1 (March 2015): 19–23, available at <https://doi.org/10.1111/1468-0009.12100> (last visited July 29, 2019);

Abayomi ,

Katz ,

Spence ,

Conton , and

S. M.

J. G.

Hodge ,

Barraza ,

Measer , and

Agrawal , “Global Emergency Legal Responses to the 2014 Ebola Outbreak: Public Health and the Law,” Journal of Law, Medicine & Ethics 42, no. 4 (2014): 595–601, available at <https://doi.org/10.1111/jlme.12179> (last visited July 29, 2019).

26.

Morhard and

Katz , “Legal and Regulatory Capacity to Support the Global Health Security Agenda,” Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 12, no. 5 (September 2014): 254–262, available at <https://doi.org/10.1089/bsp.2014.0023> (last visited July 29, 2019).

27.

L. O.

Gostin ,

J. T.

Monahan ,

Kaldor ,

DeBartolo ,

Friedman , et al., “The Legal Determinants of Health: Harnessing the Power of Law for Global Health and Sustainable Development,” The Lancet 393, no. 10183 (2019): P1857-1910.

28.

L. O.

Gostin and

A. S.

Ayala , “Strengthening National Security By Protecting Public Health: Global Health Security in an Era of Explosive Pandemic Potential,” Journal of National Security Law and Policy 9 (2017): 53-80.

29.

WHO, “IHR (2005) Monitoring and Evaluation framework Joint External Evaluation tool (JEE tool) first edition,” 2016, available at <https://www.who.int/ihr/publications/WHO_HSE_GCR_2016_2/en/> (last visited July 29, 2019).

30.

F. M.

Burkle

, “Global Health Security Demands a Strong International Health Regulations Treaty and Leadership From a Highly Resourced World Health Organization,” Disaster Medicine and Public Health Preparedness 9, no. 5 (October 18, 2015): 568–580, available at <https://doi.org/10.1017/dmp.2015.26> (last visited July 29, 2019).

31.

Harman

, “Norms Won't Save You: Ebola and the Norm of Global Health Security,” Global Health Governance 10, no. 1 (2016): 11–16.

32.

Morhard and

33.

LaFond ,

Kanagat ,

Steinglass ,

Fields ,

Sequeira , and

Mookherji , “Drivers of Routine Immunization Coverage Improvement in Africa: Findings from District-Level Case Studies,” Health Policy and Planning 30, no. 3 (April 1, 2015): 298–308, available at <https://doi.org/10.1093/heapol/czu011> (last visited July 29, 2019);

Nyaku ,

Wardle ,

Vanden Eng ,

Ametewee ,

Bonsu ,

J. K. L.

Opare , and

Conklin , “Immunization Delivery in the Second Year of Life in Ghana: The Need for a Multi-Faceted Approach,” The Pan African Medical Journal 27, no. Suppl. 3 (2017): 4, available at <https://doi.org/10.11604/pamj.supp.2017.27.3.12182> (last visited July 2019).

34.

B. M.

Meier ,

Tureski ,

Bockh ,

Carr ,

Ayala ,

Roberts ,

Cloud ,

Wilhelm , and

35.

Dwyer

, “Experimental Ebola Vaccinations, Considered ‘Paradigm Shift,’ Begin In Congo: The Two-Way : NPR,” National Public Radio, available at <https://www.npr.org/sections/thetwo-way/2018/05/21/612994193/experimental-ebola-vaccinations-considered-paradigm-shift-begin-in-congo> (last visited July 29, 2019).

36.

Burris ,

Hitchcock ,

Ibrahim ,

Penn , and

Ramanathan , “Policy Surveillance: A Vital Public Health Practice Comes of Age: Table 1,” Journal of Health Politics, Policy and Law 41, no. 6 (2016): 1151–1173, available at <https://doi.org/10.1215/03616878-3665931> (last visited July 29, 2019).

37.

Y. T.

Yang ,

J. E.

Painter , and

B. M.

Meier , “Coordinated Regulatory Efforts Needed to Strengthen Travel Related Immunization Requirements against Importation of Infectious Diseases,” Vaccine 34, no. 34 (2016): 3921–3922, available at <https://doi.org/10.1016/j.vaccine.2016.06.047> (last visited July 29, 2019).

38.

See eg Portant Attributions, Organisation Et Fonctionnement Du Ministere De La Sante, 2006 (Benin); See eg Portant organisation du Ministère de la Santé et de l'Action Sociale, 1991 (Burkina Faso).

39.

See e.g. Code de la Sante, 1997 (Guinea).

40.

See e.g. Nigerian Public Health Act, 2014 (Nigeria).

41.

See e.g. Arrête Interministériel Fixant La Liste Des Vacci-nations Obligatoires, Leurs Calendriers Et Les Conditions D'administration Des Vaccins, 2008 (Mali).

42.

C. J. E.

Metcalf ,

Ferrari ,

A. L.

Graham , and

B. T.

Grenfell , “Understanding Herd Immunity,” Trends in Immunology 36, no. 12 (December 2015): 753–755, available at <https://doi.org/10.1016/j.it.2015.10.004> (last visited July 29, 2019).

43.

R. J.

Leggiadro

, “Vaccine Refusal, Mandatory Immunization, and the Risk of Vaccine-Preventable Diseases,” The Pediatric Infectious Disease Journal 28, no. 7 (July 2009): 613, available at <https://doi.org/10.1097/INF.0b013e3181aecf5e> (last visited July 29, 2019).

44.

D. A.

Salmon ,

S. P.

Teret ,

C. R.

MacIntyre ,

Salisbury ,

M. A.

Burgess , and

N. A.

Halsey , “Compulsory Vaccination and Conscientious or Philosophical Exemptions: Past, Present, and Future,” The Lancet 367, no. 9508 (2006): 436–442, available at <https://doi.org/10.1016/S0140-6736(06)68144-0> (last visited July 29, 2019).

45.

Id.

46.

L. O.

Gostin and

L. F.

Wiley , Public Health Law: Power, Duty, Restraint (Oakland, CA: University of California Press, 2016).

47.

Jacobson v. Massachusetts, 197 U.S. 11, 25 (1905).

48.

Jacobson v. Massachusetts, 197 U.S. 11, 25 (1905).

49.

K. M.

Malone and

A. R.

Hunman , “Vaccination Mandates : The Public Health Imperative and Individual Rights,” in Law in Public Health Practice (New York: Oxford University Press, 2003): 262-284.

50.

See e.g. Public Health Act, 2009 (Tanzania).

51.

See e.g. Code de la Sante, 2009 (Togo).

52.

See e.g. Vaccination Act, 1919 (Ghana).

53.

See e.g. Immunization of Children Act, 1956 (Liberia).

54.

See e.g. Arrête Interministériel Fixant La Liste Des Vacci-nations Obligatoires, Leurs Calendriers Et Les Conditions D'administration Des Vaccins, 2008 (Mali).

55.

See e.g. Public Health Act, 1935 (Uganda); See e.g. Nigerian Public Health Act, 2014 (Nigeria).

56.

See e.g. Public Health Act of 1986, art 109 (Kenya); See e.g. Vaccination Act, 1919 (Ghana); See eg Public Health Act, 1935 (Uganda).

57.

Wang ,

Clymer ,

Davis-Hayes , and

Buttenheim , “Non-medical Exemptions From School Immunization Requirements: A Systematic Review,” American Journal of Public Health 104, no. 11 (2014): e62–84, available at <https://doi.org/10.2105/AJPH.2014.302190> (last visited July 29, 2019).

58.

J. P.

Cole and

K. S.

Swendiman , “Mandatory Vaccinations: Precedent and Current Laws,” 2014, available at <https://fas.org/sgp/crs/misc/RS21414.pdf> (last visited August 30, 2019).

59.

Id.

60.

J. W.

Thompson ,

Tyson ,

Card-Higginson ,

R. F.

Jacobs ,

J. G.

Wheeler ,

Simpson ,

J. E.

Bost ,

K. W.

Ryan , and

D. A.

Salmon , “Impact of Addition of Philosophical Exemptions on Childhood Immunization Rates,” American Journal of Preventive Medicine 32, no. 3 (2007): 194–201; available at <https://doi.org/10.1016/j.amepre.2006.10.014> (last visited July 29, 2019).

61.

See e.g. Public Health Act, 1986 (Kenya).

62.

See e.g. Vaccination Act, 1919 (Ghana).

63.

Popova and

Ibarra de Palacios , “Reaching More Children with Vaccines in Developing Countries: Key Challenges of Innovation and Delivery,” Current Medical Research and Opinion 32, no. 1 (2016): 177-181, doi: 10.1185/03007995.2015.1108910.

64.

World Health Organization, “Global Vaccine Safety Initiative,” Geneva, 2015, available at <http://www.who.int/vaccine_safety/publications/09_29_15_WHP_GVS_AR_2015_web_Single.pdf> (last visited July 29, 2019).

65.

See e.g. Vaccination Act, 1919 (Ghana).

66.

Yen ,

T. B.

Hyde ,

A. J.

Costa ,

Fernandez ,

J. S.

Tam ,

Hugonnet ,

A. M.

Huvos ,

Duclos ,

V. J.

Dietz , and

B. T.

Burkholder , “The Development of Global Vaccine Stockpiles,” The Lancet. Infectious Diseases 15, no. 3 (2015): 340–347, available at <https://doi.org/10.1016/S1473-3099(14)70999-5> (last visited July 29, 2019).

67.

See e.g. Kenya Medical Supplies Authority Act, 2013 (Kenya).

68.

See e.g. National Pharmaceutical Procurement Unit Act, 2012 (Sierra Leone).

69.

Massachusetts Department of Public Health Division of Epidemiology and Immunization, “2018 Guidelines for Compliance with Federal and State Vaccine Administration Requirements,” 2018, available at <https://www.mass.gov/service-details/vaccine-management> (last visited August 30, 2019).

70.

See e.g. Public Health Law, 1976 (Liberia).

71.

See e.g. Inter-ministerial Orders setting the List of Compulsory Vaccinations, Their Calendars and Conditions of Vaccine Administration, 2008 (Mali).

72.

World Health Organization, “2017 Assessment Report of the Global Vaccine Action Plan Strategic Advisory Group of Experts on Immunization,” Geneva, 2017, available at <http://apps.who.int/> (last visited July 29, 2019).

73.

See e.g. Public Health Act, 1935 (Uganda); See e.g. Vaccination Act, 1919 (Ghana); See e.g. Public Health Act, 1986 (Kenya).

74.

75.

See e.g. National Drug Policy and Authority Act, 1993 (Uganda).

76.

See e.g. Medicines & Health Products Regulatory Authority (LMHRA) Act, 2010 (Liberia).

77.

See e.g. Public Health Act, 1935 (Uganda); See e.g. Vaccination Act, 1919 (Ghana); See e.g. Public Health Act, 1986 (Kenya).

78.

L. O.

Gostin ,

M. M.

Kavanagh , and

Cameron , “Ebola and War in the Democratic Republic of Congo: Avoiding Failure and Thinking Ahead,” JAMA 321, no. 3 (2019): 243-244.

79.

World Health Organization, “WHO Drug Information,” 2017, available at <www.tga.gov.au> (last visited July 29, 2019).

80.

L. O.

Gostin

, Global Health Law (Cambridge: Harvard University Press, 2014).

81.

Berkley

, “Political Will and Vaccine Legislation,” Vaccine (in press).

82.

Burris ,

M. L.

Berman ,

Penn , and

T. R.

Holiday , The New Public Health Law (New York: Oxford University Press, 2018).

83.

Sunshine ,

Pepin ,

Cetron , and

Penn , “State and Territorial Ebola Screening, Monitoring, and Movement Policy Statements — United States, August 31, 2015,” MMWR. Morbidity and Mortality Weekly Report 64, no. 40 (October 16, 2015): 1145–1146, available at <https://doi.org/10.15585/mmwr.mm6440a4> (last visited July 29, 2019).

84.

Burris ,

Ashe ,

Levin ,

Penn , and

Larkin , “A Transdisciplinary Approach to Public Health Law: The Emerging Practice of Legal Epidemiology,” Annual Review of Public Health 37, no. 1 (2016): 135–148, available at <https://doi.org/10.1146/annurev-publhealth-032315-021841> (last visited July 29, 2019).

85.

E. D.

Penfold and

Fourie , “Regional Health Governance: A Suggested Agenda for Southern African Health Diplomacy,” Global Social Policy 15, no. 3 (2015): 278–295.

86.

B. M.

Meier ,

D. P.

Evans , and

Phelan , “Infectious Diseases in the New Millennium: Legal and Ethical Challenges,” in Rights-Based Approaches to Preventing, Detecting, and Responding to Infectious Disease Outbreaks, edited by

M.I.

Eccleston-Turner and

Brassington (forthcoming).

87.

See Id.

88.

L. O.

Gostin ,

M. M.

Kavanagh , and

Cameron , “Ebola and War in the Democratic Republic of Congo: Avoiding Failure and Thinking Ahead,” JAMA 321, no. 3 (2019): 243-244.

89.

L. O.

Gostin

, Global Health Law (Cambridge: Harvard University Press, 2014).